Schwartze J T, Landgraf K, Spielau U, Rockstroh D, Löffler D, Kratzsch J, Kiess W, Körner A
Department of Women's and Child Health, Center for Pediatric Research Leipzig (CPL), University Hospital for Children &Adolescents, University of Leipzig, Leipzig, Germany.
Medical Faculty, Medical Center AdiposityDiseases (IFB), University of Leipzig, Leipzig, Germany.
Int J Obes (Lond). 2017 Jun;41(6):955-963. doi: 10.1038/ijo.2017.54. Epub 2016 Dec 5.
BACKGROUND/OBJECTIVES: The recently identified adipocytokine C1QTNF5 (encodes for CTRP5) has been demonstrated to inhibit pro-metabolic insulin signaling in adipocytes. We hypothesized that adipocyte C1QTNF5 expression in subcutaneous (sc) adipose tissue (AT) would correlate with the degree of obesity, systemic CTRP5 serum levels, and early AT and metabolic dysfunction in children.
SUBJECTS/METHODS: Sc AT samples were obtained from 33 healthy Caucasian lean children aged 10.06±4.84 years and 42 overweight and obese children aged 13.34±3.12 years. C1QTNF5 expression in sc AT as well as in investigated cell lines was assessed by quantitative real-time PCR. Systemic CTRP5 levels were assessed by ELISA.
C1QTNF5 expression in sc adipocytes increased with body mass index (BMI) standard deviation score (SDS; R=0.48, P<0.001), body fat percentage (R=0.4, P=0.004), adipocyte number (R=0.69, P<0.001) and systemic CTRP5 serum levels (R=0.28, P=0.025) whereas expression in the stromal vascular fraction (SVF) was inversely correlated with BMI SDS (R=-0.24, P=0.04). Multiple regression analysis confirmed that BMI SDS was the strongest independent predictor for C1QTNF5 expression in sc adipocytes. SVF C1QTNF5 levels strongly correlated with SVF CD31 expression (R=0.54, P<0.001) indicating expression by endothelial cells. Primary human endothelial cells demonstrated stronger expression compared with human Simpson-Golahbi-Behmel syndrome pre-adipocytes and adipocytes. Adipocyte C1QTNF5 expression levels were BMI-dependently related to fasting insulin (R=0.3, P=0.03) and leptin serum levels (R=0.5, P<0.001). Sc AT samples containing crown-like structures (CLS) demonstrated increased adipocyte C1QTNF5 expression compared to CLS-negative samples (P=0.03). Functionally, tumor necrosis factor (TNF)α caused a fourfold induction of C1QTNF5 in human adipocytes (P<0.001) and a 50% reduction in primary human endothelial cells (P<0.001).
In children adipocyte C1QTNF5 expression is already strongly related to the degree of obesity and is associated with obesity-related AT alterations, systemic CTRP5 serum levels as well as circulating markers of metabolic disease and is positively regulated by TNFα in vitro.
背景/目的:最近发现的脂肪细胞因子C1QTNF5(编码CTRP5)已被证明可抑制脂肪细胞中的促代谢胰岛素信号传导。我们推测,皮下(sc)脂肪组织(AT)中脂肪细胞C1QTNF5的表达与儿童肥胖程度、全身CTRP5血清水平以及早期AT和代谢功能障碍相关。
对象/方法:从33名年龄为10.06±4.84岁的健康白种人瘦儿童和42名年龄为13.34±3.12岁的超重和肥胖儿童中获取sc AT样本。通过定量实时PCR评估sc AT以及所研究细胞系中C1QTNF5的表达。通过ELISA评估全身CTRP5水平。
sc脂肪细胞中C1QTNF5的表达随体重指数(BMI)标准差评分(SDS;R = 0.48,P < 0.001)、体脂百分比(R = 0.4,P = 0.004)、脂肪细胞数量(R = 0.69,P < 0.001)和全身CTRP5血清水平(R = 0.28,P = 0.025)增加,而基质血管部分(SVF)中的表达与BMI SDS呈负相关(R = -0.24,P = 0.04)。多元回归分析证实,BMI SDS是sc脂肪细胞中C1QTNF5表达的最强独立预测因子。SVF C1QTNF5水平与SVF CD31表达密切相关(R = 0.54,P < 0.001),表明内皮细胞表达。与人类辛普森-戈拉比-贝梅尔综合征前脂肪细胞和脂肪细胞相比,原代人内皮细胞表现出更强的表达。脂肪细胞C1QTNF5表达水平与空腹胰岛素(R = 0.3,P = 0.03)和瘦素血清水平(R = 0.5,P < 0.0